Skip to main content
. Author manuscript; available in PMC: 2015 Oct 29.
Published in final edited form as: Eur Cell Mater. 2015 Sep 21;30:118–131. doi: 10.22203/ecm.v030a09

Fig. 4.

Fig. 4

BMP-2 content of defects treated with genetically modified sheep muscle. BMP-2 content within extracts of rat femur defects was measured by ELISA and standardised to total protein. * indicates a significant increase (p < 0.05) of 3 d group compared to all other groups; $ indicates a significant increase (p < 0.05) of 1 week (wk) group compared to all later time points.